The clinicopathological significance and predictive value for immunotherapy of programmed death ligand-1 expression in Epstein-Barr virus-associated gastric cancer

The effect of anti-programmed cell death 1 (PD-1) antibody in Epstein-Barr virus-associated gastric cancer (EBVaGC) was debatable, and no predictive biomarkers for efficacy have been reported. Public reports on anti-PD-1 antibody monotherapy-treated EBVaGC with available programmed death ligand-1 (P...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Xiao-Li, Liu, Qian-Wen, Liu, Fu-Rong, Yuan, Sha-Sha, Li, Xiao-Fen, Li, Jia-Ning, Yang, An-Li, Ling, Yi-Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216206/
https://www.ncbi.nlm.nih.gov/pubmed/34235004
http://dx.doi.org/10.1080/2162402X.2021.1938381

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216206/
https://www.ncbi.nlm.nih.gov/pubmed/34235004
http://dx.doi.org/10.1080/2162402X.2021.1938381

Ejemplares similares